Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again.
Adobe
By Andrew Joseph
May 1, 2026
Europe Correspondent
Andrew Joseph
Emilia McLaughlin’s Kyron.bio is reshaping drug manufacturing—and breaking barriers as a solo female biotech founder in Europe.
Mary Catchpole, 19, receives ‘life-changing’ treatment for immune condition after NHS approval
Some boys had astonishing recoveries. But other boys died. Now Astellas is returning to revised gene therapy for XLMTM.
The companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.
Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.
Scientists hope AlphaGenome programme ushers in new era of personalised medicine
